BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 15519517)

  • 1. Development of a questionnaire module to supplement the EORTC QLQ-C30 to assess quality of life in patients with hepatocellular carcinoma, the EORTC QLQ-HCC18.
    Blazeby JM; Currie E; Zee BC; Chie WC; Poon RT; Garden OJ;
    Eur J Cancer; 2004 Nov; 40(16):2439-44. PubMed ID: 15519517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The EORTC QLQ-HDC29: a supplementary module assessing the quality of life during and after high-dose chemotherapy and stem cell transplantation.
    Velikova G; Weis J; Hjermstad MJ; Kopp M; Morris P; Watson M; Sezer O;
    Eur J Cancer; 2007 Jan; 43(1):87-94. PubMed ID: 17081744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The EORTC QLQ-OH17: a supplementary module to the EORTC QLQ-C30 for assessment of oral health and quality of life in cancer patients.
    Hjermstad MJ; Bergenmar M; Fisher SE; Montel S; Nicolatou-Galitis O; Raber-Durlacher J; Singer S; Verdonck-de Leeuw I; Weis J; Yarom N; Herlofson BB
    Eur J Cancer; 2012 Sep; 48(14):2203-11. PubMed ID: 22572480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24.
    Greimel ER; Kuljanic Vlasic K; Waldenstrom AC; Duric VM; Jensen PT; Singer S; Chie W; Nordin A; Bjelic Radisic V; Wydra D;
    Cancer; 2006 Oct; 107(8):1812-22. PubMed ID: 16977652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptoms and quality of life in chronic pancreatitis assessed by structured interview and the EORTC QLQ-C30 and QLQ-PAN26.
    Fitzsimmons D; Kahl S; Butturini G; van Wyk M; Bornman P; Bassi C; Malfertheiner P; George SL; Johnson CD
    Am J Gastroenterol; 2005 Apr; 100(4):918-26. PubMed ID: 15784041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a disease-specific Quality of Life questionnaire module for patients with gastrointestinal neuroendocrine tumours.
    Davies AH; Larsson G; Ardill J; Friend E; Jones L; Falconi M; Bettini R; Koller M; Sezer O; Fleissner C; Taal B; Blazeby JM; Ramage JK;
    Eur J Cancer; 2006 Mar; 42(4):477-84. PubMed ID: 16412628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
    Park KU
    Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer.
    Blazeby JM; Conroy T; Bottomley A; Vickery C; Arraras J; Sezer O; Moore J; Koller M; Turhal NS; Stuart R; Van Cutsem E; D'haese S; Coens C;
    Eur J Cancer; 2004 Oct; 40(15):2260-8. PubMed ID: 15454251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an EORTC module to improve quality of life assessment in patients with gastric cancer.
    Vickery CW; Blazeby JM; Conroy T; Johnson CD; Alderson D
    Br J Surg; 2000 Mar; 87(3):362-73. PubMed ID: 10718972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-OG25, to assess health-related quality of life in patients with cancer of the oesophagus, the oesophago-gastric junction and the stomach.
    Lagergren P; Fayers P; Conroy T; Stein HJ; Sezer O; Hardwick R; Hammerlid E; Bottomley A; Van Cutsem E; Blazeby JM;
    Eur J Cancer; 2007 Sep; 43(14):2066-73. PubMed ID: 17702567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a European organization for research and treatment of cancer module to assess the quality of life of patients with proctitis after pelvic radiotherapy for malignancy.
    Spry N; Halkett G; Aoun S; Spry J; Yeoh E
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):522-8. PubMed ID: 18374505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The EORTC ophthalmic oncology quality of life questionnaire module (EORTC QLQ-OPT30). Development and pre-testing (Phase I-III).
    Brandberg Y; Damato B; Kivelä T; Kock E; Seregard S; ;
    Eye (Lond); 2004 Mar; 18(3):283-9. PubMed ID: 15004578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the Japanese version of the EORTC hepatocellular carcinoma-specific quality of life questionnaire module (QLQ-HCC18).
    Mikoshiba N; Tateishi R; Tanaka M; Sakai T; Blazeby JM; Kokudo N; Koike K; Kazuma K
    Health Qual Life Outcomes; 2012 May; 10():58. PubMed ID: 22651810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Quality of life assessment in pancreatic carcinoma: results of an European multicentric study].
    Bassi C; Johnson C; Fitzsimmons D; Falconi M; Butturini G; Contro C; Frigerio I; Pederzoli P
    Chir Ital; 1999; 51(5):359-66. PubMed ID: 10738609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30.
    Guzelant A; Goksel T; Ozkok S; Tasbakan S; Aysan T; Bottomley A
    Eur J Cancer Care (Engl); 2004 May; 13(2):135-44. PubMed ID: 15115469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life in patients with hepatocellular carcinoma received surgical resection.
    Lee LJ; Chen CH; Yao G; Chung CW; Sheu JC; Lee PH; Tsai YJ; Wang JD
    J Surg Oncol; 2007 Jan; 95(1):34-9. PubMed ID: 17192864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the EORTC QLQ-BM22, the module for patients with bone metastases.
    Chow E; Bottomley A
    Expert Rev Pharmacoecon Outcomes Res; 2009 Oct; 9(5):461-5. PubMed ID: 19817529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the quality of life in chronic pancreatitis using Sf-12 and EORTC Qlq-C30 questionnaires.
    Pezzilli R; Morselli-Labate AM; Fantini L; Campana D; Corinaldesi R
    Dig Liver Dis; 2007 Dec; 39(12):1077-86. PubMed ID: 17692582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of quality of life of nasopharyngeal carcinoma patients with EORTC QLQ-C30 and H&N-35 modules.
    Cengiz M; Ozyar E; Esassolak M; Altun M; Akmansu M; Sen M; Uzel O; Yavuz A; Dalmaz G; Uzal C; Hiçsönmez A; Sarihan S; Kaplan B; Atasoy BM; Ulutin C; Abacioğlu U; Demiral AN; Hayran M
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1347-53. PubMed ID: 16169671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International cross-cultural field validation of an European Organization for Research and Treatment of Cancer questionnaire module for patients with primary liver cancer, the European Organization for Research and Treatment of Cancer quality-of-life questionnaire HCC18.
    Chie WC; Blazeby JM; Hsiao CF; Chiu HC; Poon RT; Mikoshiba N; Al-Kadhimi G; Heaton N; Calara J; Collins P; Caddick K; Costantini A; Vilgrain V; Trinquart L; Chiang C;
    Hepatology; 2012 Apr; 55(4):1122-9. PubMed ID: 22105642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.